SOM 7.25% 37.0¢ somnomed limited

in difficult market times everyone needs sleep

  1. 723 Posts.
    Great ann. Wow.

    Thousand are looking for sleep bec. of big head from finanz worries.

    SomnoMed to benefit from US Medicare decision
    MAS the best alternative to CPAP
    17 March 2008, Sydney: SomnoMed Limited (ASX: SOM), maker of sleep apnoea devices
    worldwide, could benefit tremendously from a recent decision by the US-based Centers for
    Medicare and Medicaid Services (CMS) to subsidise medical devices following a positive at-home
    sleep test. This means that a patient with obstructive sleep apnoea (OSA) can be prescribed with a
    treatment device based on data collected from home testing kits.

 
watchlist Created with Sketch. Add SOM (ASX) to my watchlist
(20min delay)
Last
37.0¢
Change
0.025(7.25%)
Mkt cap ! $79.96M
Open High Low Value Volume
35.5¢ 37.0¢ 35.0¢ $17.57K 49.36K

Buyers (Bids)

No. Vol. Price($)
1 842 35.0¢
 

Sellers (Offers)

Price($) Vol. No.
40.0¢ 75000 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
SOM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.